...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Td waterhouse

Nobody will be happier if someone suddenly “anti’s up” and buys the private held company in the next year or so. $10 per share or more would be great...all contingent on “out of the ballpark continued science revelations.”

Share
New Message
Please login to post a reply